← All organizations
Highest phase reached
Phase 2
First clinical trial
Mar 1, 2009Last known activity
Nov 1, 2021
Acquired by Biontech on Apr 1, 2016
Timeline
1990s
- Jan 1, 1997
4SC AG— Founded
2010s
- Apr 1, 2016
Biontech— Acquired By
Drugs by trial phase (15 distinct, 16 trials)
Phase 2 (13 own, 0 via acquisition)
Indications
Studied for
- Arthritis
- Arthritis, Rheumatoid
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Merkel Cell
- Colorectal Neoplasms
- Gastrointestinal Neoplasms
- Hodgkin Disease
- Inflammatory Bowel Diseases
- Intestinal Diseases
- Lymphoma
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Cutaneous
- Melanoma
- Mycoses
- Mycosis Fungoides
- Neoplasms
- Sezary Syndrome
- Syndrome
Recent trials (16)
- NCT04874831Lead sponsorPhase 2Nov 1, 2021
- NCT04955340Lead sponsorPhase 1Sep 27, 2021
- NCT04871594CollaboratorPhase 1Aug 23, 2021
- NCT04393753Lead sponsorPhase 2Jul 31, 2020
- NCT04133948CollaboratorPhase 1/Phase 2Dec 31, 2019
- NCT03812796CollaboratorPhase 2Jan 11, 2019
- NCT03278665Lead sponsorPhase 1/Phase 2Sep 25, 2017
- NCT02953301Lead sponsorPhase 2Nov 1, 2016
- NCT01344707Lead sponsorPhase 1Mar 1, 2011
- NCT01277406Lead sponsorPhase 1/Phase 2Jan 1, 2011
- NCT01054937Lead sponsorPhase 1Jan 1, 2010
- NCT01065025Lead sponsorPhase 1Jan 1, 2010
- NCT01037478Lead sponsorPhase 2Dec 1, 2009
- NCT01010581Lead sponsorPhase 2Nov 1, 2009
- NCT00943449Lead sponsorPhase 2Jul 1, 2009
Details
- Founded
- Planegg, DE Jan 1, 1997
- Last known activity
- Nov 1, 2021